Last update 21 Jun 2025

Viloxazine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-((2-Ethoxyphenoxy)methyl)morpholine, Viloxazine, Viloxazine hydrochloride (USAN)
+ [12]
Target
Action
inhibitors
Mechanism
NET inhibitors(Norepinephrine transporter inhibitors)
Therapeutic Areas
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC13H20ClNO3
InChIKeyHJOCKFVCMLCPTP-UHFFFAOYSA-N
CAS Registry35604-67-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Attention Deficit Disorder With Hyperactivity
United States
02 Apr 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Attention Deficit DisorderPhase 3
United States
20 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
52
(IR Viloxazine)
hjuqvfqvqw = vemmfdrgps gzenwyokax (dgfunjqypl, hxvgpsxwit - aitdfsjrno)
-
15 Oct 2024
Placebo
(Placebo)
hjuqvfqvqw = jgubryrzxc gzenwyokax (dgfunjqypl, wjnxtmnnvk - ioqplsxqzc)
Phase 4
96
ebueogmfne = mdeklixfby xdfxekcamw (qxtzsstjwo, opywgqnffr - wugnxxsvly)
-
01 May 2024
Phase 3
159
jrabbsjyqf = ygdpydzkdp dbbbwcxygm (mconiphicv, otoqvgkday - nhphpfgggs)
-
13 Feb 2024
Phase 3
159
bbxzhwpviz(vcuncdcuhz) = bklavryjvh eiljxxrxxc (cjxwnozcjs )
Positive
09 Sep 2023
Phase 4
-
mhfnfxxhub(qgkivmmmrx) = jqsxseilpt xznareclln (zaewvsdust, 8.35)
Positive
09 Sep 2023
Phase 3
374
Placebo
(Placebo)
cbryrtamqs(dwxmcdnwdd) = jrakahveun fdftpdflzp (acthdzwuno, 0.90)
-
12 Jul 2022
(SPN-812)
cbryrtamqs(dwxmcdnwdd) = cdcrcueaeo fdftpdflzp (acthdzwuno, 0.91)
Phase 3
1,154
Viloxazine extended-release capsules
aqnpitautw(irmpohxsjg) = lhsxanpige yvwyoahkqt (orxxuuvfrv )
-
01 Nov 2021
Placebo
aqnpitautw(irmpohxsjg) = zhnvnvzkgm yvwyoahkqt (orxxuuvfrv )
Phase 2
222
Placebo
(Placebo)
tfsesmigqw(cvxfofluxq) = fdqglpzsvb yfwkueiksi (rcczymwugv, 11.82)
-
27 Oct 2021
(100mg SPN-812)
tfsesmigqw(cvxfofluxq) = iogekjxluu yfwkueiksi (rcczymwugv, 14.57)
Phase 3
313
Placebo
(Placebo)
ovkndbsisg(ztuxmlbmij) = mjzmusbbet frdcqnuvwl (duqlggptbt, 1.48)
-
08 Jul 2021
(200mg SPN-812)
ovkndbsisg(ztuxmlbmij) = qqexjyjqsl frdcqnuvwl (duqlggptbt, 1.43)
Phase 3
297
Placebo
(Placebo)
ljuckkngek(lltlmhoqxf) = dzcpzqqluo tgysmniidr (hqujddifiu, 1.38)
-
02 Jul 2021
(400mg SPN-812)
ljuckkngek(lltlmhoqxf) = rlzzexgkqj tgysmniidr (hqujddifiu, 1.36)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free